Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Monsanto Buys Assets Of Two Biotech Firms

by Melody M. Bomgardner
February 11, 2013 | A version of this story appeared in Volume 91, Issue 6

Agriculture giant Monsanto has bought significant assets from two plant biotechnology firms. Monsanto will absorb the plant traits business of Rosetta Green, an Israeli company that specializes in using microRNA genes to improve major crops. The purchase, worth $35 million, is pending approval by the Israeli government. Separately, Monsanto bought a collection of microbes that can improve crop productivity from Agradis, a spin-off of Synthetic Genomics, for an undisclosed sum. Monsanto also signed a multiyear research deal with Synthetic Genomics to screen microbe-plant communities for beneficial microbes.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.